Tandem Diabetes Care Inc (NAS:TNDM)
$ 37.37 0.37 (1%) Market Cap: 2.45 Bil Enterprise Value: 2.43 Bil PE Ratio: 0 PB Ratio: 10.32 GF Score: 80/100

Tandem Diabetes Care Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 11, 2023 / 05:35PM GMT
Release Date Price: $23.61 (+0.51%)
Unidentified Analyst

All right. Why don't we kick this off? So it's Patrick on the U.S. Medtech team.

I got the exciting disclaimers for you guys. So for the disclosures, please go to Morgan Stanley research disclosures website at morganstanley.com/researchdisclosures. I'm sure all will be going there. If you have any questions, feel free to reach out to your sales rep. So I'll say there bye-bye.

So massive thank you to Tandem. We've got John Sheridan, obviously, and Leigh Vosseller here, agreed to join us as CEO and CFO. An open fireside chat should be a lot of fun. So thank you for joining us.

John F. Sheridan
Tandem Diabetes Care, Inc. - President, CEO & Director

Nice to be here, Patrick.

Questions & Answers

Unidentified Analyst;John F. Sheridan<

Thank you. Maybe as an opener, just to sort of set the scene, what do you feel gives Tandem its competitive edge in the pump market overall? And how do you feel like what's the DNA of the company that really gives the edge to Tandem?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot